For assistance, call 1-855-727-6274
For assistance, please contact a Dedicated Patient Case Coordinator by dialing 1-855-727-6274

Making
a real
difference
in people's
lives

The Otsuka Patient Assistance Foundation, Inc. (OPAF)
is a nonprofit organization that provides patients
with prescribed Otsuka medication free of cost.

The Otsuka Patient Assistance
Foundation, Inc. (OPAF) is a
nonprofit organization that provides
patients with prescribed Otsuka
medication free of cost.

The Otsuka Patient Assistance Foundation, Inc. (OPAF)
is a nonprofit organization that provides patients
with prescribed Otsuka medication free of cost.

The Otsuka Patient Assistance Foundation, Inc. (OPAF)
is a nonprofit organization that provides patients
with prescribed Otsuka medication free of cost.

Patients Who Are Prescribed JYNARQUE™ (tolvaptan)
May Now Be Eligible for Assistance!

OPAF is extending no cost coverage to eligible patients who are being treated with:

Jynarque (tolvaptan)

 

Please see U.S. FULL PRESCRIBING INFORMATION,
including BOXED WARNING and MEDICATION GUIDE.

How to Apply

Eligible patients can receive no cost coverage for certain Otsuka medications through OPAF.

Check eligibility for Otsuka Patient Assistance Foundation

Check Patient Eligibility

Download Otsuka Patient Assistance Foundation application

Download Application

Mail or Fax application

Submit Application

Get Started

Supported Medications

OPAF provides the following prescribed medications free of cost:

OPAF provides the following
prescribed medications free of cost:

ABILIFY® (aripiprazole) Tablets
ABILIFY MAINTENA® (aripiprazole) for extended injectable suspension
JYNARQUE™ (tolvaptan)
REXULTI® (brexpiprazole) tablets
SAMSCA® (tolvaptan)

See U.S. FULL PRESCRIBING INFORMATION,
including BOXED WARNING for
ABILIFY, ABILIFY MAINTENA, JYNARQUE,
REXULTI, and SAMSCA.

See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for
ABILIFY, ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.

See MEDICATION GUIDES for
ABILIFY, ABILIFY MAINTENA, JYNARQUE,
REXULTI, and SAMSCA.

See MEDICATION GUIDES for ABILIFY, ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.

To report SUSPECTED ADVERSE REACTIONS,
contact Otsuka America Pharmaceutical, Inc.
at 1-800-438-9927 or FDA at 1-800-FDA-1088
(www.fda.gov/medwatch).

To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at
1-800-438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).

Otsuka America Pharmaceutical, Inc. does not control or influence how Otsuka Patient Assistance Foundation distributes funds.

Are you sure you want to leave Otsuka Patient Assistance Foundation?